FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2622626142> ?p ?o ?g. }

• W2622626142 endingPage "e013802" @default.
• W2622626142 startingPage "e013802" @default.
• W2622626142 abstract "<h3>Introduction</h3> The primary aim of this study is to compare the efficacy of three short-term glucose-lowering interventions (exercise, metformin and dapagliflozin) on glycaemic variability in overweight or obese men and women with elevated diabetes risk (ie, prediabetes, defined as haemoglobin A_1c (HbA_1c)39–47 mmol/mol / 5.7%–6.4%). The secondary aims are to investigate the effects of the interventions on body composition and cardiometabolic risk factors. <h3>Methods and analysis</h3> The Pre-D Trial is an investigator-initiated, randomised, controlled, parallel, open-label, superiority trial. The study aims to assign 120 participants in a 1:1:1:1 ratio to receive one of four interventions for 13 weeks: (1) dapagliflozin (10 mg once daily); (2) metformin (850 mg twice daily); (3) exercise (interval training, 5 days a week, 30 min per session); or (4) control (lifestyle advice). After the 13 weeks of intervention, a follow-up period of 13 weeks will follow to study the long-term effects of the interventions. The primary endpoint is reduction from baseline to end-of treatment (13 weeks) in mean amplitude of glycaemic excursions measured by continuous glucose monitoring. The secondary endpoints include concomitant changes in various measures of glucose metabolism, body weight, cardiorespiratory fitness, blood pressure, plasma lipids, objectively measured physical activity and dietary intake. <h3>Ethics and dissemination</h3> The study protocol has been approved by the Ethics Committee of the Capital Region and the Danish Medicines Agency. Approval of data and biobank storage has been obtained from the Danish Data Protection Board. The study will be carried out according to the Declaration of Helsinki and to the regulations for good clinical practice. The results from this trial will allow a number of research questions concerning the effect of exercise versus dapagliflozin or metformin in HbA_1c-defined prediabetes to be addressed. <h3>Trial registration</h3> NCT02695810" @default.
• W2622626142 created "2017-06-15" @default.
• W2622626142 creator A5009197107 @default.
• W2622626142 creator A5012676820 @default.
• W2622626142 creator A5029813708 @default.
• W2622626142 creator A5033826448 @default.
• W2622626142 creator A5051857476 @default.
• W2622626142 creator A5065063436 @default.
• W2622626142 creator A5080910955 @default.
• W2622626142 date "2017-05-01" @default.
• W2622626142 modified "2023-09-25" @default.
• W2622626142 title "Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)" @default.
• W2622626142 cites W1596187835 @default.
• W2622626142 cites W1792680009 @default.
• W2622626142 cites W1935869323 @default.
• W2622626142 cites W1967265218 @default.
• W2622626142 cites W1979160337 @default.
• W2622626142 cites W1981101443 @default.
• W2622626142 cites W1986057976 @default.
• W2622626142 cites W1994576689 @default.
• W2622626142 cites W1996132147 @default.
• W2622626142 cites W1997018189 @default.
• W2622626142 cites W2018472564 @default.
• W2622626142 cites W2025870581 @default.
• W2622626142 cites W2037449342 @default.
• W2622626142 cites W2050160827 @default.
• W2622626142 cites W2054041452 @default.
• W2622626142 cites W2059158127 @default.
• W2622626142 cites W2066039558 @default.
• W2622626142 cites W2068445764 @default.
• W2622626142 cites W2069693418 @default.
• W2622626142 cites W2083595801 @default.
• W2622626142 cites W2087509093 @default.
• W2622626142 cites W2094461218 @default.
• W2622626142 cites W2106062778 @default.
• W2622626142 cites W2109573408 @default.
• W2622626142 cites W2110171411 @default.
• W2622626142 cites W2115792610 @default.
• W2622626142 cites W2118261488 @default.
• W2622626142 cites W2118782038 @default.
• W2622626142 cites W2119981294 @default.
• W2622626142 cites W2120175636 @default.
• W2622626142 cites W2120291589 @default.
• W2622626142 cites W2123919079 @default.
• W2622626142 cites W2125943156 @default.
• W2622626142 cites W2130400490 @default.
• W2622626142 cites W2130695219 @default.
• W2622626142 cites W2130756579 @default.
• W2622626142 cites W2131135469 @default.
• W2622626142 cites W2131343868 @default.
• W2622626142 cites W2132259774 @default.
• W2622626142 cites W2135097670 @default.
• W2622626142 cites W2137069992 @default.
• W2622626142 cites W2140183516 @default.
• W2622626142 cites W2142433177 @default.
• W2622626142 cites W2145562665 @default.
• W2622626142 cites W2146264128 @default.
• W2622626142 cites W2153652284 @default.
• W2622626142 cites W2154719797 @default.
• W2622626142 cites W2157405334 @default.
• W2622626142 cites W2158822657 @default.
• W2622626142 cites W2161315372 @default.
• W2622626142 cites W2179683524 @default.
• W2622626142 cites W2321394232 @default.
• W2622626142 cites W2324847430 @default.
• W2622626142 cites W2407779152 @default.
• W2622626142 cites W2560794920 @default.
• W2622626142 doi "https://doi.org/10.1136/bmjopen-2016-013802" @default.
• W2622626142 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5734208" @default.
• W2622626142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28592573" @default.
• W2622626142 hasPublicationYear "2017" @default.
• W2622626142 type Work @default.
• W2622626142 sameAs 2622626142 @default.
• W2622626142 citedByCount "15" @default.
• W2622626142 countsByYear W26226261422017 @default.
• W2622626142 countsByYear W26226261422019 @default.
• W2622626142 countsByYear W26226261422020 @default.
• W2622626142 countsByYear W26226261422021 @default.
• W2622626142 countsByYear W26226261422022 @default.
• W2622626142 countsByYear W26226261422023 @default.
• W2622626142 crossrefType "journal-article" @default.
• W2622626142 hasAuthorship W2622626142A5009197107 @default.
• W2622626142 hasAuthorship W2622626142A5012676820 @default.
• W2622626142 hasAuthorship W2622626142A5029813708 @default.
• W2622626142 hasAuthorship W2622626142A5033826448 @default.
• W2622626142 hasAuthorship W2622626142A5051857476 @default.
• W2622626142 hasAuthorship W2622626142A5065063436 @default.
• W2622626142 hasAuthorship W2622626142A5080910955 @default.
• W2622626142 hasBestOaLocation W26226261421 @default.
• W2622626142 hasConcept C117437137 @default.
• W2622626142 hasConcept C126322002 @default.
• W2622626142 hasConcept C134018914 @default.
• W2622626142 hasConcept C168563851 @default.
• W2622626142 hasConcept C1862650 @default.
• W2622626142 hasConcept C2777180221 @default.
• W2622626142 hasConcept C2777422806 @default.
• W2622626142 hasConcept C2779668308 @default.
• W2622626142 hasConcept C2780221984 @default.

• next